EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 335 filers reported holding EXELIXIS INC in Q4 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,995 | +27.4% | 2,009 | +5.2% | 0.00% | 0.0% |
| Q4 2022 | $30,620 | -28.8% | 1,909 | -19.1% | 0.00% | 0.0% |
| Q2 2021 | $43,000 | -8.5% | 2,360 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $47,000 | +113.6% | 2,360 | +164.0% | 0.00% | +100.0% |
| Q3 2020 | $22,000 | +69.2% | 894 | +17.6% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | +62.5% | 760 | +60.0% | 0.00% | – |
| Q4 2019 | $8,000 | -94.3% | 475 | -92.8% | 0.00% | -100.0% |
| Q3 2019 | $141,000 | 0.0% | 6,585 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $141,000 | -47.6% | 6,585 | -41.8% | 0.01% | -52.6% |
| Q1 2019 | $269,000 | +43.9% | 11,310 | +18.9% | 0.02% | +18.8% |
| Q4 2018 | $187,000 | +2237.5% | 9,515 | +1903.2% | 0.02% | +1500.0% |
| Q3 2018 | $8,000 | -20.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | – | 475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |